High Sierra Technologies, Inc. (HSTI)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | -0.02 USD | -8.11% |
| 2021 | -0.02 USD | -5.71% |
| 2020 | -0.02 USD | 27.39% |
| 2019 | -0.02 USD | -760.71% |
| 2018 | -0.00 USD | 89.55% |
| 2017 | -0.03 USD | -11.67% |
| 2016 | -0.02 USD | 20.53% |
| 2015 | -0.03 USD | -29.61% |
| 2014 | -0.02 USD | -33.14% |
| 2013 | -0.02 USD | 0.0% |
| 2012 | -0.02 USD | 0.0% |
| 2011 | -0.02 USD | -50.86% |
| 2010 | -0.01 USD | 0.0% |
| 2009 | -0.01 USD | 0.0% |
| 2008 | -0.01 USD | 1.69% |
| 2007 | -0.01 USD | 38.54% |
| 2006 | -0.02 USD | -156.0% |
| 2005 | -0.01 USD | -31.58% |
| 2004 | -0.01 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q1 | -0.00 USD | 32.35% |
| 2023 Q2 | -0.00 USD | -2.17% |
| 2023 Q3 | -0.00 USD | 2.13% |
| 2022 Q1 | -0.01 USD | -229.41% |
| 2022 FY | - USD | -8.11% |
| 2022 Q4 | -0.01 USD | -161.54% |
| 2022 Q3 | -0.00 USD | -4.0% |
| 2022 Q2 | -0.00 USD | 55.36% |
| 2021 Q1 | -0.00 USD | 57.14% |
| 2021 Q4 | -0.00 USD | 74.24% |
| 2021 FY | - USD | -5.71% |
| 2021 Q2 | -0.00 USD | 26.19% |
| 2021 Q3 | -0.01 USD | -112.9% |
| 2020 Q1 | -0.00 USD | -114.0% |
| 2020 Q3 | -0.00 USD | -43.75% |
| 2020 Q2 | -0.00 USD | -14.29% |
| 2020 FY | - USD | 27.39% |
| 2020 Q4 | -0.01 USD | -326.09% |
| 2019 FY | - USD | -760.71% |
| 2019 Q3 | -0.01 USD | 36.5% |
| 2019 Q1 | -0.00 USD | 0.0% |
| 2019 Q2 | -0.01 USD | -389.29% |
| 2019 Q4 | 0.01 USD | 214.94% |
| 2018 Q4 | -0.00 USD | -109.33% |
| 2018 Q1 | -0.00 USD | 32.14% |
| 2018 Q3 | 0.03 USD | 383.02% |
| 2018 Q2 | -0.01 USD | -178.95% |
| 2018 FY | - USD | 89.55% |
| 2017 Q3 | -0.01 USD | 43.0% |
| 2017 FY | - USD | -11.67% |
| 2017 Q4 | -0.01 USD | 1.75% |
| 2017 Q2 | -0.01 USD | -85.19% |
| 2017 Q1 | -0.01 USD | -1.89% |
| 2016 Q4 | -0.01 USD | 14.52% |
| 2016 Q3 | -0.01 USD | 25.3% |
| 2016 FY | - USD | 20.53% |
| 2016 Q2 | -0.01 USD | -97.62% |
| 2016 Q1 | -0.00 USD | 30.0% |
| 2015 Q2 | -0.01 USD | -180.0% |
| 2015 Q1 | -0.00 USD | 34.78% |
| 2015 Q4 | -0.01 USD | 15.49% |
| 2015 FY | - USD | -29.61% |
| 2015 Q3 | -0.01 USD | 43.65% |
| 2014 FY | - USD | -33.14% |
| 2014 Q4 | -0.01 USD | -16.95% |
| 2014 Q3 | -0.01 USD | -68.57% |
| 2014 Q2 | -0.00 USD | 37.5% |
| 2014 Q1 | -0.01 USD | -30.23% |
| 2013 Q1 | -0.00 USD | 41.46% |
| 2013 Q2 | -0.01 USD | -212.5% |
| 2013 Q3 | -0.00 USD | 38.67% |
| 2013 Q4 | -0.00 USD | 6.52% |
| 2013 FY | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | -0.00 USD | -28.95% |
| 2012 Q2 | -0.00 USD | 9.52% |
| 2012 Q4 | -0.00 USD | 16.33% |
| 2012 Q1 | -0.00 USD | 4.55% |
| 2011 Q1 | -0.00 USD | -67.86% |
| 2011 Q2 | -0.00 USD | 27.66% |
| 2011 Q3 | -0.00 USD | 8.82% |
| 2011 FY | - USD | -50.86% |
| 2011 Q4 | -0.00 USD | -41.94% |
| 2010 Q3 | -0.00 USD | 45.45% |
| 2010 Q2 | -0.00 USD | -51.72% |
| 2010 Q1 | -0.00 USD | -11.54% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | -0.00 USD | -16.67% |
| 2009 Q3 | -0.00 USD | 27.27% |
| 2009 Q2 | -0.00 USD | 19.51% |
| 2009 Q1 | -0.00 USD | -95.24% |
| 2009 Q4 | -0.00 USD | -8.33% |
| 2009 FY | - USD | 0.0% |
| 2008 Q1 | -0.00 USD | -60.0% |
| 2008 Q4 | -0.00 USD | 0.0% |
| 2008 Q3 | -0.00 USD | 43.24% |
| 2008 Q2 | -0.00 USD | -15.63% |
| 2008 FY | - USD | 1.69% |
| 2007 Q1 | -0.00 USD | -168.75% |
| 2007 Q2 | -0.01 USD | -18.6% |
| 2007 FY | - USD | 38.54% |
| 2007 Q3 | -0.00 USD | 62.75% |
| 2007 Q4 | -0.00 USD | -5.26% |
| 2006 Q4 | -0.00 USD | 70.91% |
| 2006 Q3 | -0.01 USD | 52.17% |
| 2006 Q1 | -0.00 USD | 0.0% |
| 2006 FY | - USD | -156.0% |
| 2006 Q2 | -0.01 USD | -1816.67% |
| 2005 Q1 | -0.83 USD | 0.0% |
| 2005 Q2 | -3.38 USD | -307.23% |
| 2005 Q3 | -0.83 USD | 75.44% |
| 2005 Q4 | -0.00 USD | 99.93% |
| 2005 FY | - USD | -31.58% |
| 2004 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioQuest Corp. | - USD | Infinity% |
| GSRX Industries Inc. | - USD | Infinity% |
| Instadose Pharma Corp. | - USD | Infinity% |